Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT)
David M. Pariser(Eastern Virginia Medical School), Laurent Eckert(Sanofi (France)), Thomas Bieber(CK-CARE), David J. Margolis(University of Pennsylvania), Usha G. Mallya, T. Michelle Brown(RTI Health Solutions), Lauren Nelson(RTI Health Solutions), Isabelle Guillemin, Abhijit Gadkari(Regeneron (United States)), Matthew Reaney(Sanofi (United Kingdom)), Puneet Mahajan(Research Triangle Park Foundation), Eric L. Simpson(Oregon Health & Science University)
Cited by 138
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011
|JAMA|2016|1.8k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k
Guidelines of care for the management of atopic dermatitis
|Journal of the American Academy of Dermatology|2013|1.3k